The StubHub IPO: navigating the high-stakes world of ticket resale

As someone who’s chased down tickets for everything from sold-out rock shows to buzzer-beater basketball games, I’ve got a love-hate relationship with the secondary market. That’s why the recent StubHub IPO hit close to home for me. On September 17, 2025, the company finally went public on the NYSE under the ticker STUB, pricing shares … Read more

It’s all about the PE ratios

In the ruthless arena of investing where wealth is forged or incinerated in moments, the price-to-earnings ratio stands as the ultimate truth-teller. The PE ratio cuts through the fog of market hype and meme-fueled stonks, exposing a company’s valuation against its earnings. It’s the line between a potential moonshot and a financial dumpster fire. Below, … Read more

Why I’m pumped about $HIMS: top 10 things making this telehealth company the next big stonks bet

With the healthcare and beauty industries exploding, $HIMS is positioned to surf that wave into millionaire-maker territory. Let me break down the top 10 reasons I’m hyped AF for this play—fundamentals, fresh cash flows, subs that stick like glue, M&A firepower, and the macro tailwinds that scream “buy the dip”: Whew, there you have it—$HIMS … Read more

CPI is officially a non-event: a Stonks and Whatnot vibe check

Alright fam, let’s talk about the Consumer Price Index (CPI) real quick. I’m sitting here sipping my overpriced coffee, scrolling through the X timeline, and I see the usual suspects hyping up CPI release day like it’s the Super Bowl of markets. “Inflation data droppin’! S&P 500 about to moon or get yeeted!” Bro, chill. … Read more